Repositorio Dspace

Listar por tema "Neoplasm Recurrence, Local/pathology"

Listar por tema "Neoplasm Recurrence, Local/pathology"

Ordenar por:Orden:Resultados:

  • Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced Prostate Carcinoma 
    Vidal-Crespo, Natalia; Enguita-Arnal, Laura; Gómez-Ferrer, Álvaro; Collado-Serra, Argimiro; Mascaros, Juan-Manuel; Calatrava-Fons, Ana; Casanova-Ramón-Borja, Juan; Rubio-Briones, José; Ramírez-Backhaus, Miguel (MDPI, 2022-08)
    Background and Objectives: Patients with seminal vesicle invasion (SVI) are a highly heterogeneous group. Prognosis can be affected by many clinical and pathological characteristics. Our aim was to study whether bilateral ...
  • Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer 
    Feliciangeli-Moreno, Eduardo; Albaladejo-González, Ana; García-Rodríguez, José; Lázaro-Sánchez, Antonio-David; Borg, Rosanna; Pimentel-Cáceres, Paola; Soriano-Polo, Diego; Rodríguez-Braun, Edith; Balsalobre-Yago, José; Martínez-Ortiz, María-José; Wikstrom-Fernández, Sofía; Murillo-Herrera, Andrés; García-García, Teresa; García-Solano, José; Conesa-Zamora, Pablo; Luengo-Gil, Ginés (NATURE PORTFOLIO, 2025-07-01)
    This study examined the prognostic significance of immunoscore within consensus molecular subtypes (CMS), tumour budding (TB), and macrophage infiltration in colorectal cancer (CRC). A retrospective series was analysed ...
  • Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment? 
    de-la-Calva-Ceinos, Carolina; DENO-Res-Grp, Manuel; Angulo, Manuel; González-Rojo, Paula; Peiró, Ana; Machado, Pau; Cebrian, Juan-Luis; García-Maroto, Roberto; Valcárcel, Antonio; Puertas, Pablo; Valero-Cifuentes, Gregorio; Pablos, Oscar; Maireles, Miriam; Fontalva, María-Luisa; Chaves, Iván; Orce, Aida; Coll-Mesa, Luis; Pérez, Israel; González, Fausto; del-Carmen-Sanz, María; Gracia, Isidro (WILEY, 2025-01)
    BACKGROUND: Denosumab represents a valuable treatment option for unresectable giant cell tumors of the bone (GCTBs). However, no standardized protocols exist determining the length of administration, with few studies having ...